دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The Lucy Letby case: lessons for health systems
doi : 10.1016/S0140-6736(23)01839-1
Volume 402, Issue 10404, 2–8 September 2023, Page 747
Atogepant, the first oral preventive treatment for chronic migraine
*Kristian A Haanes, Lars Edvinsson
doi : 10.1016/S0140-6736(23)01462-9
Volume 402, Issue 10404, 2–8 September 2023, Pages 748-749
Interventions to prevent dementia should target those at high risk
*Gill Livingston, Sergi G Costafreda
doi : 10.1016/S0140-6736(23)01472-1
Volume 402, Issue 10404, 2–8 September 2023, Pages 750-751
Should adjuvant nivolumab be used in surgically resected Merkel cell carcinoma patients?
*Philippe Saiag, Astrid Blom
doi : 10.1016/S0140-6736(23)01041-3
Volume 402, Issue 10404, 2–8 September 2023, Pages 751-753
Advancing integrated governance for health through national biodiversity strategies and action plans
Liz Willetts, Carly Siege, Anna M Stewart-Ibarra, Ojistoh Horn, Benjamas Chotthong, Tanirat Tanawat, Phyllis Omido, Manushi Sharma, Lujain Alqodmani, Nathan J Bennett, Christopher D Golden, Cicilia Wangari Githaiga, Neil M Vora
doi : 10.1016/S0140-6736(23)01431-9
Volume 402, Issue 10404, 2–8 September 2023, Pages 753-756
What water will the UN Conference carry forward: a fundamental human right or a commodity?
Léo Heller, Meera Karunananthan, Margreet Zwarteveen, David Hall, Mary Ann Manahan, Fatou Diouf
doi : 10.1016/S0140-6736(23)01430-7
Volume 402, Issue 10404, 2–8 September 2023, Pages 757-759
Offline: Primary healthcare is not enough
Richard Horton
doi : 10.1016/S0140-6736(23)01843-3
Volume 402, Issue 10404, 2–8 September 2023, Page 760
The Voice key for Indigenous Australian's health
Chris McCall
doi : 10.1016/S0140-6736(23)01840-8
Volume 402, Issue 10404, 2–8 September 2023, Pages 761-762
WHO's new vision for traditional medicine
Talha Burki
doi : 10.1016/S0140-6736(23)01841-X
Volume 402, Issue 10404, 2–8 September 2023, Pages 763-764
Deus Bazira: finding new solutions to key global health challenges
Udani Samarasekera
doi : 10.1016/S0140-6736(23)01804-4
Volume 402, Issue 10404, 2–8 September 2023, Page 765
The others in the roomFive Tuesdays in winter,
Dmitriy Petrov, *Daniel Marchalik
doi : 10.1016/S0140-6736(23)01805-6
Volume 402, Issue 10404, 2–8 September 2023, Page 766
Alice Ball: chemist who developed a treatment for leprosy
Georgina Ferry
doi : 10.1016/S0140-6736(23)01806-8
Volume 402, Issue 10404, 2–8 September 2023, Page 767
Bushra Mohammed Ibnauf Sulieman
Andrew Green
doi : 10.1016/S0140-6736(23)01807-X
Volume 402, Issue 10404, 2–8 September 2023, Page 768
Reauthorise PEPFAR to prevent death, orphanhood, and suffering for millions of children
Lucie Cluver, Jeffrey W Imai-Eaton, Lorraine Sherr, Mary Mahy, Seth Flaxman
doi : 10.1016/S0140-6736(23)01723-3
Volume 402, Issue 10404, 2–8 September 2023, Pages 769-770
Commending Public Health Scotland's evaluation of minimum unit pricing
Ian Gilmore, Ilora Finlay, Martin McKee, Michael Marmot, Sally Casswell, Peter Rice, *Katherine Severi
doi : 10.1016/S0140-6736(23)01584-2
Volume 402, Issue 10404, 2–8 September 2023, Page 771
Bold moves for vaccine manufacturing equity
Ole Kristian Aars, *Nina Schwalbe
doi : 10.1016/S0140-6736(23)01414-9
Volume 402, Issue 10404, 2–8 September 2023, Pages 771-772
Human rights violations in Ukraine: the need for forensic investigations
Constantine Eliopoulos
doi : 10.1016/S0140-6736(23)01372-7
Volume 402, Issue 10404, 2–8 September 2023, Pages 772-773
What constitutes high-quality evidence for malaria vector control?
William A Hawley, Ferdinand J Laihad, Eric Ochomo, Nicole L Achee, John P Grieco, Jennifer S Armistead, Bernard L Nahlen
doi : 10.1016/S0140-6736(23)01423-X
Volume 402, Issue 10404, 2–8 September 2023, Pages 773-774
Zanzibar's malaria elimination efforts: progress, challenges, and lessons
Sanun Ally Kessy, Jovin R Tibenderana
doi : 10.1016/S0140-6736(23)01467-8
Volume 402, Issue 10404, 2–8 September 2023, Page 774
Department of Error
doi : 10.1016/S0140-6736(23)01812-3
Volume 402, Issue 10404, 2–8 September 2023, Page 774
Department of Error
doi : 10.1016/S0140-6736(23)01811-1
Volume 402, Issue 10404, 2–8 September 2023, Page 774
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Patricia Pozo-Rosich, Jessica Ailani, Messoud Ashina, Peter J Goadsby, Richard B Lipton, Uwe Reuter, Hua Guo, Brittany Schwefel, Kaifeng Lu, Ramesh Boinpally, Rosa Miceli, Rosa De Abreu Ferreira, Emily McCusker, Sung Yun Yu, Lawrence Severt, Michelle Finnegan, Joel M Trugman
doi : 10.1016/S0140-6736(23)01049-8
Volume 402, Issue 10404, 2–8 September 2023, Pages 775-785
Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial
Frank R Lin, James R Pike, Marilyn S Albert, Michelle Arnold, Sheila Burgard, Theresa Chisolm, David Couper, Jennifer A Deal, Adele M Goman, Nancy W Glynn, Theresa Gmelin, Lisa Gravens-Mueller, Kathleen M Hayden, Alison R Huang, David Knopman, Christine M Mitchell, Thomas Mosley, James S Pankow, Nicholas S Reed, Victoria Sanchez, Jennifer A Schrack, B Gwen Windham, Josef Coresh, for the ACHIEVE Collaborative Research Group
doi : 10.1016/S0140-6736(23)01406-X
Volume 402, Issue 10404, 2–8 September 2023, Pages 786-797
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
Jürgen C Becker, Selma Ugurel, Ulrike Leiter, Friedegund Meier, Ralf Gutzmer, Sebastian Haferkamp, Lisa Zimmer, Elisabeth Livingstone, Thomas K Eigentler, Axel Hauschild, Felix Kiecker, Jessica C Hassel, Peter Mohr, Michael Fluck, Ioannis Thomas, Marlene Garzarolli, Imke Grimmelmann, Konstantin Drexler, Alexandra N Spillner, Sebastian Eckhardt, Dirk Schadendorf, on behalf of DeCOG
doi : 10.1016/S0140-6736(23)00769-9
Volume 402, Issue 10404, 2–8 September 2023, Pages 798-808
Regression of cutaneous xanthomata in patient with homozygous familial hypercholesterolemia using novel therapies
Brett Stephen Mansfield, Frederick J Raal
doi : 10.1016/S0140-6736(23)01515-5
Volume 402, Issue 10404, 2–8 September 2023, Page e11
Childhood nephrotic syndrome
Marina Vivarelli, Keisha Gibson, Aditi Sinha, Olivia Boyer
doi : 10.1016/S0140-6736(23)01051-6
Volume 402, Issue 10404, 2–8 September 2023, Pages 809-824
